US FDA seeks ‘boxed warning’ for CAR-T cancer therapies
By Gnaneshwar Rajan and Gursimran Mehar (Reuters) -The U.S. health regulator said on Monday companies will be required to add a serious warning on the prescribing information for cancer therapies known as CAR-T, made by Gilead Sciences, Johnson & Johnson, Novartis and others. The other cancer therapies include Bristol Myers Squibb’s Breyanzi and its partnered …
US FDA seeks ‘boxed warning’ for CAR-T cancer therapies Read More »









